___

• 1- Xiong L, Matthes JD, Li J, ve ark. MR imaging of "spray heads": toluene abuse via 2- aerosol paint inhalation. AJNR Am J Neuroradiol, 1993; 14:1195-1199. 3- Muijser H, Geuskens RB, Hooisma J, ve ark. Behavioral effects of exposure to organic solvents in carpet layers. Neurotoxicol Teratol, 1996; 18:455-462. 4- Kamran S, Bakshi R. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images. Neuroradiology, 1998; 40:519-521. 5- Morrow LA, Kamis H, Hodgson MJ. Psychiatric symptomatology in persons with organic solvent exposure. J Consult Clin Psychol, 1993; 61:171-174. 6- Elofsson S, Gamberale F, Hindmarsh T et al. Exposure to organic solvents: a cross- sectional epidemiologic investigation on occupationally exposed car and industrial spray painters with special reference to the nervous system. Scan J Work Environ Health 1980; 6:239-273. 7- Lazar R, Su H, Melen O, Daghestani A. Multifocal central nervous system damage caused by toluene abuse. Neurology, 1983; 33:1337-1340. 8- Yazıcı MK, Demir B, Tanrıverdi N ve ark. Hamilton anksiyete değerlendirme ölçeği, değerlendiriciler arası güvenirlik ve geçerlik çalışması. Türk Psikiyatri Dergisi 1998; 9:114- 117. 9- Çorapcıoğlu A, Aydemir O, Yıldız M ve ark. DSM-IV için yapılandırılmış klinik görüşme formu. Hekimler Yayın Birliği 1999, Ankara. 10- Eisenberg DP. Neurotoxicity and mechanism of toluene abuse. Einstein Quart J Biol Med 2003; 19:150-159. 11 - Uchino A, Kato A, YuzurihaT, et al. Comparison between patient characteristics and cranial MR findings in chronic thinner intoxication. Eur Radiol 2002; 12:1338-1341. 12- Ukai H, Watanabe T, Nakatsuka H, et al. Dose-dependent increase in subjective symptoms among toluene exposed workers. Environ Res 1993; 60:274-289. 13- Tekgül H, Dizdarer G, Yalman O, ve ark. Associated brain abnormalities in patients with corpus callosum anomalies. Turk J Pediatr 1999; 41:173-180. 14- Taylor M, David AS. Agenesis of the corpus callosum: a United Kingdom series of 56 cases. J Neurol Neurosurg Psychiatry 1998; 64:131-134 15- Schaumburg HH. Toluene. Experimental and clinical neurotoxicology. New York: Oxford University Press, 2000: 1183-1189. 16- Gelenberg AJ, Lydiard RB, Rudolph RL et al. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. JAMA, 2000 ; 21,283:3082-3088 17- Baker EL, Seppalainen AM. Session 3. Human aspects of solvent neurobehavioral effects. Report of the workshop session on clinical and epidemiologicaltopics. Neurotoxicology, 1986; 7:43-56. 18- Rickert CH, Karger B, Varchmin-Schultheiss K, et al. Neglect-associated fatal Marchiafava- Bignami disease in a non-alcoholic woman. IntJ Legal Med 2001 ;115:90-93.